1. Deep learning-based automatic segmentation for size and volumetric measurement of breast cancer on magnetic resonance imaging
   Wenyi Yue et al, 2022, Frontiers in Oncology CrossRef
2. Assessment of PD‐L1 expression and tumor‐infiltrating lymphocytes (TILs) across molecular subtypes of triple‐negative breast cancer
   Ridhi Sood et al, 2020, The Breast Journal CrossRef
3. Molecular Subtyping of Triple Negative Breast Cancer by Surrogate Immunohistochemistry Markers
   Sandeep Kumar et al, 2021, Applied Immunohistochemistry & Molecular Morphology CrossRef
4. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)
   Abeer H. Abdelhafez et al, 2021, Breast Cancer Research and Treatment CrossRef
5. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
   Silvana Anna Maria Urru et al, 2018, BMC Cancer CrossRef
6. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
   Mahdi Abdoli Shadbad et al, 2021, Frontiers in Oncology CrossRef
7. Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative Breast Cancer Subtypes
   Nah Ihm Kim et al, 2022, Applied Immunohistochemistry & Molecular Morphology CrossRef
8. Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
   Asad Mustafa Karim et al, 2023, Biochemical Pharmacology CrossRef
9. A triple-negative breast cancer surrogate subtype classification that correlates with gene expression subtypes
   Tae-Kyung Yoo et al, 2022, Breast Cancer Research and Treatment CrossRef
10. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo
    Hassan Moghtaderi et al, 2017, Biomedicine & Pharmacotherapy CrossRef
11. Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
    Qiang Wu et al, 2019, Frontiers in Oncology CrossRef
12. Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines
    Nath�lia Sonehara et al, 2018, Oncology Letters CrossRef
13. Tumor-infiltrating lymphocyte volume is a better predictor of neoadjuvant therapy response and overall survival in triple-negative invasive breast cancer
    Lin Zhang et al, 2018, Human Pathology CrossRef
14. Prognostic value of the Ki-67 proliferation index in patients with triple negative breast carcinoma. Preliminary report
    Ángel Fernández et al, 2020, Investigación Clínica CrossRef